// App-Quantinova.ai

PB1415 : Use of recombinant von Willebrand factor concentrate for peri-partum haemostatic management of women with type 2 VWD; a case series

Researchers

Presenter

  • O. Turan

Principal Investigators

  • M. Musarara

  • R. Abdul-Kadir

Medical Centers

  • Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free London NHS Foundation Trust, London, United Kingdom

  • Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital NHS Trust London, London, England, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved